|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07H 7/04 | (2006.01) |
| C07H 15/20 | (2006.01) | ||
| A61K 31/70 | (2006.01) |
| (11) | Number of the document | 1506211 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03736643.2 |
| Date of filing the European patent application | 2003-05-15 | |
| (97) | Date of publication of the European application | 2005-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2007-02-07 |
| (46) | Date of publication of the claims translation | 2007-05-25 |
| (86) | Number | PCT/US2003/015591 |
| Date | 2003-05-15 |
| (87) | Number | WO 2003/099836 |
| Date | 2003-12-04 |
| (30) | Number | Date | Country code |
| 151436 | 2002-05-20 | US |
| (72) |
ELLSWORTH, Bruce, US
WASHBURN, William, N., US
SHER, Philip, M., US
WU, Gang, US
MENG, Wei, US
|
| (73) |
AstraZeneca AB,
., SE-151 85, Södertälje,
SE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | C-Arilgliukozido SGLT2 inhibitoriai ir būdas |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD |
| Payment date | Validity (years) | Amount | |
| 2022-04-19 | 347.00 EUR |